| Record ID | marc_records_scriblio_net/part18.dat:98303577:959 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part18.dat:98303577:959?format=raw |
LEADER: 00959cam 2200229 a 4500
001 85227396 //r88
003 DLC
005 19880321000000.0
008 851112s1985 onca bs f00010 eng
010 $a 85227396 //r88
020 $a0660118351 (pbk.) :$c$19.25 ($23.10 other countries)
043 $an-cn---
050 0 $aHD9670.C22$bC325 1985
082 0 $a338.4/76151/0971$219
110 10 $aCanada.$bCommission of Inquiry on the Pharmaceutical Industry.
245 10 $aReport of the Commission of Inquiry on the Pharmaceutical Industry /$cHarry C. Eastman ... [et al.].
260 0 $a[Toronto, Ont. :$bThe Commission] ;$aOttawa, Canada :$bAvailable by mail from Canadian Govt. Pub. Centre, Supply and Services Canada,$cc1985.
300 $axxxvi, 474 p. :$bill. ;$c25 cm.
504 $aBibliography: p. 471-474.
650 0 $aPharmaceutical industry$zCanada.
650 0 $aPharmaceutical industry$zCanada$xState supervision.
700 10 $aEastman, Harry C.,$d1923-